What is a mucinous cystadenocarcinoma?

A mucinous cystadenocarcinoma is a malignant tumor that arises in glandular tissue with an encapsulated structure and mucus-producing cells. These tumors can arise in many different types of tissue, including the breasts, ovaries, and kidneys. They are often not diagnosed until they have reached an advanced stage because symptoms may be relatively minimal. Treatments include surgery and chemotherapy, supervised by an oncologist who may be assisted by other medical professionals, depending on the location of the tumor.

While the term "mucinous cystadenocarcinoma" can be a mouthful, when broken down into its components, it is easier to understand, and the same terminology used to talk about this type of tumor is also used in other medical settings. "Mucinous" indicates the presence of mucus in or around the tumor. A "cyst" is a pocket of tissue, often filled with fluid. "Adeno" indicates that the growth is of glandular origin, and "carcinoma" means that it is malignant, as seen in the term "adenocarcinoma" to describe a malignant tumor arising in the glands.

When a mucinous cystadenocarcinoma is located in the abdomen, it can cause abdominal pain and tenderness along with ascites, water deposits in the abdomen that cause swelling and discomfort. Patients may also experience abnormalities in endocrine function caused by cancer cells, such as spikes in the levels of certain hormones. Mucinous cystadenocarcinomas can cause infertility, impaired kidney function, and a variety of other symptoms.

Medical imaging studies can be used to locate a mucinous cystadenocarcinoma and check for signs of spread. Growth biopsy procedures can provide more information about the source and stage of the tumor. This information is important to have when developing a treatment plan, as it can have an impact on the treatments offered to the patient.

Surgery to remove the tumor is the first-line treatment. During surgery, the surgeon will try to remove all of the intact growth to reduce the risk of leaving cancer cells behind and to prevent the mucinous cystadenocarcinoma from rupturing and killing cancer cells in the process. A pathologist can examine the tumor to see if the surgeon removed the tumor with a margin of healthy cells, which increases the chance that all of the cancer cells will be removed. Chemotherapy is offered after surgery to kill any remaining cancer cells in the body, including cells that the surgeon might have been forced to leave behind if it was impossible to remove the entire tumor.

Go up